{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:34:10Z","timestamp":1780472050211,"version":"3.54.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Raynaud's phenomenon (RP) is a clinical syndrome characterized by recurrent episodes of digital vasospasm triggered by exposure to physical and chemical agents or emotional stress. Although many pharmacologic treatments have been tested, there is still no cure or gold standard therapy. Botulinum toxin treatment has been proved to reduce pain and increase arterial blood flow in treated hands of adult patients with RP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The aim of this study is to evaluate the efficacy of botulinum toxin A on younger than 18-year-old patients with primary and secondary RP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A single-center prospective study was performed, including 8 patients aged 14 to 17 years who were clinically diagnosed with primary or secondary RP. BTX was injected into each hand without sedation or anesthetic blockade. The primary outcome was pain reduction after BTX injection. Pain intensity was evaluated at baseline and in the first follow-up. Secondary outcomes included variations in the number and severity of RP episodes after the BTX injection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>All patients stated significant pain reduction and decreased cold sensitivity, except one patient who did not feel any changes. No patients reported any loss of strength on thumb-index finger.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>BTX injection is a simple, noninvasive, and cost-effective treatment alternative, offering an important nonsurgical therapeutic option for the pediatric population. It could also help optimize the dose of other treatments used in these patients. The most commonly observed positive effect is a reduction in the pain associated with RP attacks. Further studies are needed to confirm these results.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002397","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T21:34:45Z","timestamp":1588714485000},"page":"61-64","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Botulinum Toxin A Treatment for Primary and Secondary Raynaud's Phenomenon in Teenagers"],"prefix":"10.1097","volume":"47","author":[{"given":"Luc\u00eda","family":"Quintana Castanedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Feito Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nieto Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Maseda Pedrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Chiloeches Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"de Lucas Laguna","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of Dermatology, La Paz University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1080\/09638280701679705","article-title":"Hand injuries and cold sensitivity: reliability and validity of cold sensitivity questionnaires","volume":"30","author":"Carlsson","year":"2008","journal-title":"Disabil Rehabil"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jhsa.2010.09.019","article-title":"Botulinum toxin type A in the treatment of Raynaud's phenomenon","volume":"35","author":"Neumeister","year":"2010","journal-title":"J Hand Surg Am"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PRS.0b013e3181a80576","article-title":"Botox therapy for ischemic digits","volume":"124","author":"Neumeister","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R4-20250731","first-page":"264","article-title":"Raynaud phenomenon in children","volume":"65","author":"Goldman","year":"2019","journal-title":"Can Fam Physician"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","article-title":"Management of vasospastic disorders with botulinum toxin A","volume":"119","author":"Van Beek","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.semarthrit.2011.07.006","article-title":"Botulinum toxin A treatment of Raynaud's phenomenon: a review","volume":"41","author":"Iorio","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhsa.2008.11.026","article-title":"Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon","volume":"34","author":"Fregene","year":"2009","journal-title":"J Hand Surg Am"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.hcl.2013.09.006","article-title":"Minimally invasive treatment of Raynaud phenomenon: the role of botulinum type A","volume":"30","author":"Neumeister","year":"2014","journal-title":"Hand Clin"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hcl.2014.09.003","article-title":"The role of botulinum toxin in vasospastic disorders of the hand","volume":"31","author":"Neumeister","year":"2015","journal-title":"Hand Clin"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/art.40123","article-title":"The therapeutic efficacy of botulinum toxin in treating scleroderma-associated raynaud's phenomenon: a randomized, double-blind, placebo-controlled clinical trial","volume":"69","author":"Bello","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhsa.2012.01.021","article-title":"The effect of botulinum neurotoxin-A on blood flow in rats: a potential mechanism for treatment of Raynaud phenomenon","volume":"37","author":"Stone","year":"2012","journal-title":"J Hand Surg"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2362.2004.01324.x","article-title":"Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study","volume":"34","author":"Sycha","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jdcr.2016.05.003","article-title":"Treatment of symptomatic epidermolysis bullosa simplex with botulinum toxin in a pediatric patient","volume":"2","author":"Holahan","year":"2016","journal-title":"JAAD Case Rep"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/pde.13628","article-title":"Sweaty feet in adolescents-Early use of botulinum type A toxin in juvenile plantar hyperhidrosis","volume":"35","author":"Bernhard","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cps.2011.03.010","article-title":"An overview of botulinum toxins: past, present, and future","volume":"38","author":"Cartee","year":"2011","journal-title":"Clin Plast Surg"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"R17-20250731","first-page":"V08130527","article-title":"Marked effect of botulinum toxin A for severe toe digital ulcers in a patient with systemic sclerosis","volume":"176","author":"baumgartner-nielsen","year":"2014","journal-title":"Ugeskr Laeger"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ced.13333","article-title":"Ischaemic ulcers on the toes secondary to Raynaud phenomenon in a patient with systemic sclerosis successfully treated with botulinum toxin","volume":"43","author":"Garrido-R\u00edos","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"R19-20250731","first-page":"231","article-title":"Anesthesia exposure in the young child and long-term cognition: an integrated review","volume":"87","author":"Rosenblatt","year":"2019","journal-title":"AANA J"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:12:25Z","timestamp":1753999945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002397","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]}}}